Hims & Hers Health stock breakout attempt at $32.12 resistance: Technical outlook

Traders Union
All News
Stocks
Hims & Hers up 2.16% at $31.75

Highlights

Visa has issued a notice to Hims & Hers Health due to a surge in customer complaints for its weight-loss subscription service.
Regulatory scrutiny has increased as Glancy Prongay Wolke & Rotter LLP investigates possible securities law violations linked to the company.
Shares of Hims & Hers Health advanced 2.16% to $31.75 amid high volatility, with an expected trading range of $28.63 to $34.87 over the next 2 to 3 days and a 76% probability of upward movement, although short-term technicals signal resistance and sellers dominate intraday.

Payment scrutiny and legal risks drive volatility in Hims shares

Visa Inc. has placed Hims & Hers Health Inc. on notice following a notable increase in customer complaints tied to its weight-loss subscription business, as reported by Globenewswire on August 21, 2026. This development raises concerns over the company's payment processing stability and could undermine customer trust, presenting operational risks. The ongoing investigation by Glancy Prongay Wolke & Rotter LLP into possible securities law violations adds regulatory scrutiny, with these factors contributing to active trading and renewed market attention.

Bullish momentum stalls as technical signals diverge at resistance

MA-20 at $32.12 acts as immediate short-term resistance, while the price finds support at MA-50 ($30.64) and MA-200 ($28.77). The Ichimoku Kijun is positioned at $32.38, representing another resistance level. Intraday technical signals are mixed: MACD shows a strong buy, ADX gives a buy indication, and Stochastic RSI is on buy, but RSI at 51.55 and CCI at neutral suggest a balanced structure. Bull/Bear Power points to oversold conditions, signaling that despite underlying bullish momentum, sellers maintain intraday control, and the Awesome Oscillator remains neutral. High volatility persists, with divergence between price gains and short-term momentum.

Upside favored as consolidation persists within volatile trading range

Over the next two to three trading days, HIMS is expected to consolidate in a typical volatility band from $28.63 to $34.87. Upward movement is favored with a 76% probability, while a decline carries a 24% likelihood. A move above resistance at $32.12 or $32.38 could trigger further gains, whereas losing support at $30.64 or below $28.77 may signal the start of a deeper retracement.

Viktoras Karapetjanc, expert at Traders Union, sees Hims & Hers Health maintaining short-term strength despite regulatory and reputational risks from the recent Visa notice. He notes active sentiment and persistent volatility, but believes the company’s favorable probability of further upside is supported by its fundamental position above major moving averages. Karapetjanc expects consolidation within the defined band while market participants weigh both operational uncertainties and bullish momentum signals. "A break above $32.12 or $32.38 could invite a fresh surge, so I’m watching these levels as key inflection points for the next move."

Earlier, analysts noted that Hims & Hers Health faced ongoing legal and regulatory challenges, with technical signals reflecting mixed but generally constructive momentum. The latest escalation in operational and payment processing risks adds a new layer of uncertainty, making sustained closes above the $32.38 resistance level a critical indicator for any renewed breakout potential in the near term.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.